Materials approaches for next-generation encapsulated cell therapies

Siddharth R Krishnan1,2, Robert Langer1,2,3,4,5,6, Daniel G Anderson1,2,3,5,6

  • 1David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA USA.

MRS Communications
|February 17, 2025
PubMed
Summary

Engineered biomaterials can protect transplanted cells from immune attack, enabling long-term therapy for chronic diseases like Type 1 diabetes. This approach addresses immune rejection and improves cell survival for effective in vivo drug delivery.

Related Concept Videos